Natural killer cells and innate interferon gamma participate in the host defense against respiratory vaccinia virus infection

Journal of Virology

Volumn 90, Issue 1, 2016, Pages 129-141

  Abboud, Georges ^a   Tahiliani, Vikas ^a   Desai, Pritesh ^a   Varkoly, Kyle ^a   Driver, John ^a   Hutchinson, Tarun E ^a   Salek Ardakani, Shahram ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HOST RESISTANCE; INNATE IMMUNITY; LUNG PARENCHYMA; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; OVARY; PHENOTYPE; PRIORITY JOURNAL; SURVIVAL RATE; SYMPTOM; VACCINIA VIRUS; VIRAL CLEARANCE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS LOAD; VIRUS TRANSMISSION; ANIMAL; C57BL MOUSE; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; METABOLISM; RESPIRATORY TRACT INFECTION; SURVIVAL ANALYSIS; VACCINIA; VIROLOGY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LUNG; LYMPHOCYTE DEPLETION; MICE, INBRED C57BL; MICE, KNOCKOUT; OVARY; RESPIRATORY TRACT INFECTIONS; SURVIVAL ANALYSIS; VACCINIA; VACCINIA VIRUS; VIRAL LOAD;

EID: 84953860818     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01894-15     Document Type: Article

References (66)

1. Buller RM, Palumbo GJ. 1991. Poxvirus pathogenesis. Microbiol Rev 55:80-122.
2. Di Giulio DB, Eckburg PB. 2004. Human monkeypox: an emerging zoonosis. Lancet Infect Dis 4:15-25. http://dx.doi.org/10.1016/S1473-3099(03)00856-9.
3. de Souza Trindade G, Drumond BP, Guedes MI, Leite JA, Mota BE, Campos MA, da Fonseca FG, Nogueira ML, Lobato ZI, Bonjardim CA, Ferreira PC, Kroon EG. 2007. Zoonotic vaccinia virus infection in Brazil: clinical description and implications for health professionals. J Clin Microbiol 45:1370-1372. http://dx.doi.org/10.1128/JCM.00920-06.
4. Cann JA, Jahrling PB, Hensley LE, Wahl-Jensen V. 2013. Comparative pathology of smallpox and monkeypox in man and macaques. J Comp Pathol 148:6-21. http://dx.doi.org/10.1016/j.jcpa.2012.06.007.
5. Nelson JB. 1938. The behavior of pox viruses in the respiratory tract. I. The response of mice to the nasal instillation of vaccinia virus. J Exp Med 68:401-412.
6. Turner GS. 1967. Respiratory infection of mice with vaccinia virus. J Gen Virol 1:399-402. http://dx.doi.org/10.1099/0022-1317-1-3-399.
7. Williamson JD, Reith RW, Jeffrey LJ, Arrand JR, Mackett M. 1990. Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. J Gen Virol 71(Pt 11):2761-2767. http://dx.doi.org/10.1099/0022-1317-71-11-2761.
8. Schriewer J, Buller RM, Owens G. 2004. Mouse models for studying orthopoxvirus respiratory infections. Methods Mol Biol 269:289-308. http://dx.doi.org/10.1385/1-59259-789-0:289.
9. Chapman JL, Nichols DK, Martinez MJ, Raymond JW. 2010. Animal models of orthopoxvirus infection. Vet Pathol 47:852-870. http://dx.doi.org/10.1177/0300985810378649.
10. Rivera R, Hutchens M, Luker KE, Sonstein J, Curtis JL, Luker GD. 2007. Murine alveolar macrophages limit replication of vaccinia virus. Virology 363:48-58. http://dx.doi.org/10.1016/j.virol.2007.01.033.
11. Bonduelle O, Duffy D, Verrier B, Combadiere C, Combadiere B. 2012. Cutting edge: protective effect of CX3CR1+ dendritic cells in a vaccinia virus pulmonary infection model. J Immunol 188:952-956. http://dx.doi.org/10.4049/jimmunol.1004164.
12. Rice AD, Turner PC, Embury JE, Moldawer LL, Baker HV, Moyer RW. 2011. Roles of vaccinia virus genes E3L and K3L and host genes PKR and RNase L during intratracheal infection of C57BL/6 mice. J Virol 85:550-567. http://dx.doi.org/10.1128/JVI.00254-10.
13. Hutchens MA, Luker KE, Sonstein J, Nunez G, Curtis JL, Luker GD. 2008. Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection. PLoS Pathog 4:e1000153. http://dx.doi.org/10.1371/journal.ppat.1000153.
14. Martinez J, Huang X, Yang Y. 2010. Direct TLR2 signaling is critical for NK cell activation and function in response to vaccinia viral infection. PLoS Pathog 6:e1000811. http://dx.doi.org/10.1371/journal.ppat.1000811.
15. Zhu J, Martinez J, Huang X, Yang Y. 2007. Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood 109:619-625. http://dx.doi.org/10.1182/blood-2006-06-027136.
16. Hutchens M, Luker KE, Sottile P, Sonstein J, Lukacs NW, Nunez G, Curtis JL, Luker GD. 2008. TLR3 increases disease morbidity and mortality from vaccinia infection. J Immunol 180:483-491. http://dx.doi.org/10.4049/jimmunol.180.1.483.
17. Yammani RD, Pejawar-Gaddy S, Gurley TC, Weimer ET, Hiltbold EM, Alexander-Miller MA. 2008. Regulation of maturation and activating potential in CD8+ versus CD8-dendritic cells following in vivo infection with vaccinia virus. Virology 378:142-150. http://dx.doi.org/10.1016/j.virol.2008.05.031.
18. + dendritic cell subpopulations following pulmonary poxvirus infection. J Virol 84:10191-10199. http://dx.doi.org/10.1128/JVI.00892-10.
19. Goulding J, Bogue R, Tahiliani V, Croft M, Salek-Ardakani S. 2012. CD8 T cells are essential for recovery from a respiratory vaccinia virus infection. J Immunol 189:2432-2440. http://dx.doi.org/10.4049/jimmunol.1200799.
20. Goulding J, Abboud G, Tahiliani V, Desai P, Hutchinson TE, Salek-Ardakani S. 2014. CD8 T cells use IFN-gamma to protect against the lethal effects of a respiratory poxvirus infection. J Immunol 192:5415-5425. http://dx.doi.org/10.4049/jimmunol.1400256.
21. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L, Kronenberg M, Locksley RM. 2003. Constitutive cytokine mRNAs mark natural killer (NK) andNKT cells poised for rapid effector function. J Exp Med 198:1069-1076. http://dx.doi.org/10.1084/jem.20030630.
22. Wang J, Li F, Zheng M, Sun R, Wei H, Tian Z. 2012. Lung natural killer cells in mice: phenotype and response to respiratory infection. Immunology 137:37-47. http://dx.doi.org/10.1111/j.1365-2567.2012.03607.x.
23. Hesker PR, Krupnick AS. 2013. The role of natural killer cells in pulmonary immunosurveillance. Front Biosci (Schol Ed) 5:575-587. http://dx.doi.org/10.2741/S391.
24. Fuchs A, Colonna M. 2011. Natural killer (NK) and NK-like cells at mucosal epithelia: mediators of anti-microbial defense and maintenance of tissue integrity. Eur J Microbiol Immunol (Bp) 1:257-266. http://dx.doi.org/10.1556/EuJMI.1.2011.4.1.
25. Culley FJ. 2009. Natural killer cells in infection and inflammation of the lung. Immunology 128:151-163. http://dx.doi.org/10.1111/j.1365-2567.2009.03167.x.
26. Ferlazzo G, Morandi B. 2014. Cross-talks between natural killer cells and distinct subsets of dendritic cells. Front Immunol 5:159. http://dx.doi.org/10.3389/fimmu.2014.00159.
27. Abdul-Careem MF, Mian MF, Yue G, Gillgrass A, Chenoweth MJ, Barra NG, Chew MV, Chan T, Al-Garawi AA, Jordana M, Ashkar AA. 2012. Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis 206:167-177. http://dx.doi.org/10.1093/infdis/jis340.
28. Zhou G, Juang SW, Kane KP. 2013. NK cells exacerbate the pathology of influenza virus infection in mice. Eur J Immunol 43:929-938. http://dx.doi.org/10.1002/eji.201242620.
29. Li F, Zhu H, Sun R, Wei H, Tian Z. 2012. Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection. J Virol 86:2251-2258. http://dx.doi.org/10.1128/JVI.06209-11.
30. Salek-Ardakani S, Moutaftsi M, Crotty S, Sette A, Croft M. 2008. OX40 drives protective vaccinia virus-specific CD8 T cells. J Immunol 181: 7969-7976. http://dx.doi.org/10.4049/jimmunol.181.11.7969.
31. Salek-Ardakani S, Moutaftsi M, Sette A, Croft M. 2011. Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection. J Virol 85:9051-9059. http://dx.doi.org/10.1128/JVI.00619-11.
32. Salek-Ardakani S, Arens R, Flynn R, Sette A, Schoenberger SP, Croft M. 2009. Preferential use of B7.2 and not B7.1 in priming of vaccinia virusspecific CD8 T cells. J Immunol 182:2909-2918. http://dx.doi.org/10.4049/jimmunol.0803545.
33. Tscharke DC, Karupiah G, Zhou J, Palmore T, Irvine KR, Haeryfar SM, Williams S, Sidney J, Sette A, Bennink JR, Yewdell JW. 2005. Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines. J Exp Med 201:95-104. http://dx.doi.org/10.1084/jem.20041912.
34. Moutaftsi M, Peters B, Pasquetto V, Tscharke DC, Sidney J, Bui HH, Grey H, Sette A. 2006. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol 24:817-819. http://dx.doi.org/10.1038/nbt1215.
35. Flynn R, Hutchinson T, Murphy KM, Ware CF, Croft M, Salek-Ardakani S. 2013. CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA. PLoS One 8:e77991. http://dx.doi.org/10.1371/journal.pone.0077991.
36. Wang Y, Chaudhri G, Jackson RJ, Karupiah G. 2009. IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection. J Immunol 183:3324-3331. http://dx.doi.org/10.4049/jimmunol.0803985.
37. Gherardi MM, Ramirez JC, Esteban M. 2003. IL-12 and IL-18 act in synergy to clear vaccinia virus infection: involvement of innate and adaptive components of the immune system. J Gen Virol 84:1961-1972. http://dx.doi.org/10.1099/vir.0.19120-0.
38. Di Santo JP. 2006. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 24:257-286. http://dx.doi.org/10.1146/annurev.immunol.24.021605.090700.
39. Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, Moretta L, Moretta A. 1997. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med 186:1129-1136. http://dx.doi.org/10.1084/jem.186.7.1129.
40. Kim S, Iizuka K, Kang HS, Dokun A, French AR, Greco S, Yokoyama WM. 2002. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 3:523-528. http://dx.doi.org/10.1038/ni796.
41. Rosmaraki EE, Douagi I, Roth C, Colucci F, Cumano A, Di Santo JP. 2001. Identification of committed NK cell progenitors in adult murine bone marrow. Eur J Immunol 31:1900-1909. http://dx.doi.org/10.1002/1521-4141(200106)31:6<1900::AID-IMMU1900>3.0.CO;2-M.
42. Arase H, Saito T, Phillips JH, Lanier LL. 2001. Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2). J Immunol 167:1141-1144. http://dx.doi.org/10.4049/jimmunol.167.3.1141.
43. Hayakawa Y, Smyth MJ. 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 176:1517-1524. http://dx.doi.org/10.4049/jimmunol.176.3.1517.
44. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. 2009. Maturation of mouse NK cells is a 4-stage developmental program. Blood 113:5488-5496. http://dx.doi.org/10.1182/blood-2008-10-187179.
45. Tomura M, Zhou XY, Maruo S, Ahn HJ, Hamaoka T, Okamura H, Nakanishi K, Tanimoto T, Kurimoto M, Fujiwara H. 1998. A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3-cells. J Immunol 160:4738-4746.
46. Lauwerys BR, Renauld JC, Houssiau FA. 1999. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine 11:822-830. http://dx.doi.org/10.1006/cyto.1999.0501.
47. Reinhardt RL, Liang HE, Locksley RM. 2009. Cytokine-secreting follicular T cells shape the antibody repertoire. Nat Immunol 10:385-393. http://dx.doi.org/10.1038/ni.1715.
48. Koo GC, Dumont FJ, Tutt M, Hackett J, Jr, Kumar V. 1986. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J Immunol 137:3742-3747.
49. Jacoby RO, Bhatt PN, Brownstein DG. 1989. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch Virol 108:49-58. http://dx.doi.org/10.1007/BF01313742.
50. Karupiah G, Fredrickson TN, Holmes KL, Khairallah LH, Buller RM. 1993. Importance of interferons in recovery from mousepox. J Virol 67: 4214-4226.
51. Niemialtowski MG, Spohr de Faundez I, Gierynska M, Malicka E, Toka FN, Schollenberger A, Popis A. 1994. The inflammatory and immune response to mousepox (infectious ectromelia) virus. Acta Virol 38:299-307.
52. Delano ML, Brownstein DG. 1995. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction of virus replication by cells with an NK phenotype. J Virol 69:5875-5877.
53. Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller RM. 2007. Induction of natural killer cell responses by ectromelia virus controls infection. J Virol 81:4070-4079. http://dx.doi.org/10.1128/JVI.02061-06.
54. Burshtyn DN. 2013. NK cells and poxvirus infection. Front Immunol 4:7. http://dx.doi.org/10.3389/fimmu.2013.00007.
55. Panchanathan V, Chaudhri G, Karupiah G. 2008. Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol Cell Biol 86:80-86. http://dx.doi.org/10.1038/sj.icb.7100118.
56. Fang M, Lanier LL, Sigal LJ. 2008. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. PLoS Pathog 4:e30. http://dx.doi.org/10.1371/journal.ppat.0040030.
57. Pak-Wittel MA, Yang L, Sojka DK, Rivenbark JG, Yokoyama WM. 2013. Interferon-gamma mediates chemokine-dependent recruitment of natural killer cells during viral infection. Proc Natl Acad Sci U S A 110: E50-E59. http://dx.doi.org/10.1073/pnas.1220456110.
58. McGill J, Heusel JW, Legge KL. 2009. Innate immune control and regulation of influenza virus infections. J Leukoc Biol 86:803-812. http://dx.doi.org/10.1189/jlb.0509368.
59. Usherwood EJ, Meadows SK, Crist SG, Bellfy SC, Sentman CL. 2005. Control of murine gammaherpesvirus infection is independent of NK cells. Eur J Immunol 35:2956-2961. http://dx.doi.org/10.1002/eji.200526245.
60. Mullbacher A. 2003. Cell-mediated cytotoxicity in recovery from poxvirus infections. Rev Med Virol 13:223-232. http://dx.doi.org/10.1002/rmv.381.
61. Alter G, Malenfant JM, Altfeld M. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294:15-22. http://dx.doi.org/10.1016/j.jim.2004.08.008.
62. Kohonen-Corish MR, King NJ, Woodhams CE, Ramshaw IA. 1990. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma. Eur J Immunol 20:157-161. http://dx.doi.org/10.1002/eji.1830200123.
63. Ramshaw I, Ruby J, Ramsay A, Ada G, Karupiah G. 1992. Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo. Immunol Rev 127:157-182. http://dx.doi.org/10.1111/j.1600-065X.1992.tb01413.x.
64. Karupiah G, Blanden RV, Ramshaw IA. 1990. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med 172:1495-1503. http://dx.doi.org/10.1084/jem.172.5.1495.
65. Karupiah G, Coupar BE, Andrew ME, Boyle DB, Phillips SM, Mullbacher A, Blanden RV, Ramshaw IA. 1990. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J Immunol 144:290-298.
66. Karupiah G, Woodhams CE, Blanden RV, Ramshaw IA. 1991. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice. J Immunol 147:4327-4332.